Sage Journals: Discover world-class research

Retricted access

Review article

First published 2012-8-22

Novel Disease-Modifying Therapies for Alzheimer's Disease

Teng Jiang, Jin-Tai Yu, Lan Tan

Journal of Alzheimer’s Disease

Open access

Research article

First published 2026

Rethinking our strategies to develop disease-modifying therapies for Parkinson's: Time for combination therapies?

Paloma Fernandez, Rachel M Hughes, Helen Matthews [...]

Journal of Parkinson’s Disease

Retricted access

Review article

First published 2019-10

The emergence of follow-on disease-modifying therapies for multiple sclerosis

Brandon P Moss, Jeffrey A Cohen

Multiple Sclerosis Journal

Open access

Research article

First published 2018-7

The effect of disease modifying therapies on CD62L expression in multiple sclerosis

Margarete Maria Voortman, Paul Greiner, Daniel Moser [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Open access

Review article

First published 2021

Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper)

Heinz Wiendl, Ralf Gold, Thomas Berger [...]

Therapeutic Advances in Neurological Disorders

Open access

Review article

First published 2017-9

Disease-modifying therapies in multiple sclerosis in Latin America

Eli Skromne-Eisenberg, Laura Ordoñez-Boschetti, Irene Treviño-Frenk

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Open access

Research article

First published 2024-4

Coronavirus disease 2019 infection among working-aged people with multiple sclerosis and the impact of disease-modifying therapies

Chantelle Murley, Emma Pettersson, Jan Hillert [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Retricted access

Other

First published 2009-12

Discontinuing disease-modifying therapy in progressive multiple sclerosis: can we stop what we have started?

Roisín Lonergan, Katie Kinsella, Marguerite Duggan [...]

Multiple Sclerosis Journal

Open access

Review article

First published 2021

Health economics of disease-modifying therapy for multiple sclerosis in the United States

Daniel M. Hartung

Therapeutic Advances in Neurological Disorders

Retricted access

Research article

First published 2020-10

Perspectives of individuals with multiple sclerosis on discontinuation of disease-modifying therapies

Marisa P McGinley, Philip A Cola, Robert J Fox [...]

Multiple Sclerosis Journal

Search results